logo-loader

Avita Medical receives regulatory update

Published: 05:00 15 Sep 2014 BST

au_medical_chart350_54163c21841ce

Regenerative medicine company Avita Medical (ASX:AVH) has been granted a trading halt this morning with its shares placed in pre-open.

Avita requested the halt after it received a regulatory update.

Avita develops and distributes regenerative products for the treatment of a broad range of wounds, scars and skin defects.

The company’s patented and proprietary tissue‐culture, collection and application technology provides treatment solutions derived from a patient’s own skin.

The halt will remain in place until the opening of trade on Wednesday 17th September 2014, or earlier if an announcement is made to the market.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Caledonia Mining tackles 2023 challenges with optimism for 2024 as it...

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) chief executive Mark Learmonth tells Proactive's Stephen Gunnion the company faced a challenging 2023, primarily due to poor production in the first half of the year at its core asset, the Blanket Mine in Zimbabwe, and an underperformance...

1 hour, 7 minutes ago